S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations

被引:34
作者
Becker, A
Smulders, YM
Teerlink, T
Struys, EA
de Meer, K
Kostense, PJ
Jakobs, C
Dekker, JM
Nijpels, G
Heine, RJ
Bouter, LM
Stehouwer, CDA
机构
[1] VU Univ Med Ctr, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands
[2] VU Univ Med Ctr, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands
[3] VU Univ Med Ctr, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands
[4] VU Univ Med Ctr, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands
[5] VU Univ Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
关键词
cardiovascular disease; cobalamin; folate; homocysteine; intervention trials; S-adenosylhomocysteine; S-adenosylmethionine; vitamin B-6; PLASMA HOMOCYSTEINE LEVELS; STAGE RENAL-DISEASE; VASCULAR-DISEASE; RISK FACTOR; CARDIOVASCULAR-DISEASE; HORDALAND-HOMOCYSTEINE; HEART-DISEASE; HYPERHOMOCYSTEINEMIA; DETERMINANTS; POPULATION;
D O I
10.1046/j.1365-2362.2003.01104.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is unclear whether homocysteine itself is causal in the pathogenesis of cardiovascular disease. Alternatively or additionally, the association between homocysteine and cardiovascular disease may be because of its metabolic precursor, S-adenosylhomocysteine, or of the ratio of S-adenosylmethionine to S-adenosylhomocysteine. Therefore, it is relevant to know how these moieties are interrelated, and whether, as is the case for homocysteine, they are influenced by blood levels of folate, cobalamin or vitamin B-6. Design We cross-sectionally studied A population-based cohort of 97 Caucasian subjects aged 60-85 years. Concentrations of homocysteine, S-adenosylhomocysteine, S-adenosylmethionine, folate, cobalamin and vitamin B6 were measured in fasting blood samples. Results In multiple regression analysis, homocysteine was associated with vitamin B12 (per 50 pmol L-1 increase of cobalamin, change in homocysteine, -0.70 mmol L-1; 95% CI, -1.30 to -0.10 mmol L-1) and folate (per 100 mnol L-1 increase in erythrocyte folate, change in homocysteine,-0.68 mmol L-1; 95% CI-1.28 to -0.08 mmol. L-1). S-adenosylhomocysteine, S-adenosylmethionine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine were not associated with serum folate, cobalamin or vitamin B6, nor with erythrocyte folate. Furthermore, plasma homocysteine showed a negative correlation with the ratio of Sadenosylmethionine to S-adenosylhomocysteine in plasma (r = -0.27; P < 0.01) but not in erythrocytes. Conclusions In contrast to homocysteine, the plasma concentrations of S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine were not associated with the folate, cobalamin and vitamin B6 concentrations in the present study. If these precursors in part explain why homocysteine is associated with cardiovascular disease, homocysteine-lowering treatment with B vitamins may be less effective than currently expected, at least in an elderly population.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 45 条
[1]  
[Anonymous], 1982, MINNESOTA CODE RESTI
[2]  
BEKS PJ, 1995, DIABETOLOGIA, V38, P86, DOI 10.1007/BF02369357
[3]   Consequences of homocysteine export and oxidation in the vascular system [J].
Blom, HJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (03) :227-232
[4]   Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour [J].
Bostom, AG ;
Selhub, J ;
Jacques, PF ;
Rosenberg, IH .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :133-139
[5]   Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes [J].
Bostom, AG ;
Lathrop, L .
KIDNEY INTERNATIONAL, 1997, 52 (01) :10-20
[6]   HOMOCYSTEINE AND CYSTEINE - DETERMINANTS OF PLASMA-LEVELS IN MIDDLE-AGED AND ELDERLY SUBJECTS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
ANDERSSON, A ;
HULTBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :633-641
[7]  
Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894
[8]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[9]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[10]   Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine β-synthase-deficient mice [J].
Dayal, S ;
Bottiglieri, T ;
Arning, E ;
Maeda, N ;
Malinow, MR ;
Sigmund, CD ;
Heistad, DD ;
Faraci, FM ;
Lentz, SR .
CIRCULATION RESEARCH, 2001, 88 (11) :1203-1209